Microfluidics-Assisted Engineering of pH/Enzyme Dual-Activatable ZIF@Polymer Nanosystem for Co-Delivery of Proteins and Chemotherapeutics with Enhanced Deep-Tumor Penetration

Angew Chem Int Ed Engl. 2022 Mar 28;61(14):e202113703. doi: 10.1002/anie.202113703. Epub 2022 Feb 10.

Abstract

The impermeable barriers of solid tumors restrict the co-delivery of protein-based drugs and chemotherapeutics for cancer treatment. Therefore, we developed a ZIF-DOX/RA@DG nanosystem that encapsulates ribonuclease A (RA) and doxorubicin (DOX) in a zeolitic imidazolate framework (ZIF-8) core, with a dextran-based coating (DG). The nanosystem exhibits dual-responsiveness due to γ-glutamyl transpeptidase-activatable cationization and acidic microenvironment-triggered degradation. The DG-coating process was achieved using a microfluidic approach, which stabilized the polymer responsiveness, ZIF-8-based structure, and bioactivity of the encapsulated therapeutics. In vivo results confirmed that the nanosystem could co-deliver RA and DOX to deep impermeable lesions with a synergistic anticancer therapeutic effects. Such a multi-drug delivery system based on an intelligent-responsive design and a microfluidics-assisted synthesis strategy shows great clinical prospects.

Keywords: Cancer therapy; Co-delivery; Deep penetration; Dual-responsive systems; Microfluidics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Doxorubicin / chemistry
  • Drug Delivery Systems
  • Humans
  • Hydrogen-Ion Concentration
  • Microfluidics
  • Neoplasms* / drug therapy
  • Polymers / chemistry
  • Tumor Microenvironment
  • Zeolites*

Substances

  • Polymers
  • Zeolites
  • Doxorubicin